• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The efficacy and effectiveness of drugs for diabetes: how do clinical trials and the real world compare?

作者信息

Pratley Richard E

机构信息

Florida Hospital Diabetes Institute, Orlando, FL, USA,

出版信息

Diabetologia. 2014 Jul;57(7):1273-5. doi: 10.1007/s00125-014-3263-3. Epub 2014 May 22.

DOI:10.1007/s00125-014-3263-3
PMID:24849569
Abstract
摘要

相似文献

1
The efficacy and effectiveness of drugs for diabetes: how do clinical trials and the real world compare?糖尿病药物的疗效与效果：临床试验与现实世界情况相比如何？
Diabetologia. 2014 Jul;57(7):1273-5. doi: 10.1007/s00125-014-3263-3. Epub 2014 May 22.
2
The International Diabetes Federation’s 2013 World Diabetes Congress, Melbourne, Australia.
J Diabetes. 2014 May;6(3):197-201. doi: 10.1111/1753-0407.12126. Epub 2014 Feb 24.
3
[Treatment of diabetes mellitus with a mixture of oral hypoglycemic agents].用口服降糖药混合物治疗糖尿病
Gac Med Mex. 1979 Mar;115(3):121-6.
4
Trials of new anti-diabetes agents.新型抗糖尿病药物的试验
Diabet Med. 2017 Feb;34(2):147. doi: 10.1111/dme.13306.
5
The trials and tribulations of the University Group Diabetes Program 2: lessons and reflections.大学组糖尿病项目的艰难困苦2：经验教训与反思
J R Soc Med. 2019 Dec;112(12):503-511. doi: 10.1177/0141076819890263.
6
Pilot evaluation of BL-H381 in treatment of diabetes mellitus.BL-H381治疗糖尿病的初步评估。
Curr Ther Res Clin Exp. 1966 Oct;8(10):472-8.
7
Clinical trials for treatment of NODAT: time to collaborate.治疗非糖尿病性肾移植后糖尿病的临床试验：是时候开展合作了。
Transplantation. 2012 Aug 27;94(4):e23-4; author reply e24-5. doi: 10.1097/TP.0b013e318260b1e9.
8
Glucose-lowering drugs: balancing risks and benefits.
Lancet Diabetes Endocrinol. 2017 Sep;5(9):669. doi: 10.1016/S2213-8587(17)30265-6. Epub 2017 Aug 9.
9
New horizons in diabetes treatment.糖尿病治疗的新视野。
Diabetes Self Manag. 2003 Sep-Oct;20(5):67-8, 70.
10
The use of tolazamide in the treatment of diabetes mellitus.
J Fla Med Assoc. 1966 Mar;53(3):191-3.

引用本文的文献

1
Comparison of the outcomes of the prolonged antianginal therapy use in stable coronary artery disease patients according to the data of randomized and observational studies.根据随机研究和观察性研究数据，对稳定型冠状动脉疾病患者长期使用抗心绞痛治疗的结果进行比较。
Contemp Clin Trials Commun. 2021 Feb 17;21:100743. doi: 10.1016/j.conctc.2021.100743. eCollection 2021 Mar.
2
Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States.美国2型糖尿病患者中胰高血糖素样肽-1受体激动剂治疗的真实世界依从性和停药情况
Patient Prefer Adherence. 2020 Nov 27;14:2337-2345. doi: 10.2147/PPA.S277676. eCollection 2020.
3

本文引用的文献

1
Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.维格列汀与磺脲类药物作为二甲双胍附加疗法的疗效：随机对照研究与观察性研究结果的比较
Diabetologia. 2014 Jul;57(7):1304-7. doi: 10.1007/s00125-014-3222-z. Epub 2014 Mar 29.
2
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).维格列汀二线治疗与其他口服药物治疗 2 型糖尿病的疗效和耐受性：一项真实世界的全球观察性研究（EDGE）。
Int J Clin Pract. 2013 Oct;67(10):947-56. doi: 10.1111/ijcp.12252. Epub 2013 Aug 21.
3
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.
第三届基于设备的高血压治疗临床试验欧洲临床共识会议会议记录。
Eur Heart J. 2020 Apr 21;41(16):1588-1599. doi: 10.1093/eurheartj/ehaa121.
4
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin.德谷胰岛素/利拉鲁肽（IDegLira）可维持血糖控制并改善临床结局，无论 2 型糖尿病患者在使用基础胰岛素治疗时的预试验胰岛素剂量如何，其血糖控制都不达标。
Diabet Med. 2020 Feb;37(2):267-276. doi: 10.1111/dme.14178. Epub 2019 Nov 28.
5
Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus.基础胰岛素临床试验中低血糖事件的报告：需要达成共识。
Diabetes Obes Metab. 2019 Jul;21(7):1529-1542. doi: 10.1111/dom.13732. Epub 2019 Apr 29.
6
Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal.评估新型降糖药物持续性和依从性的不同方法的效果：葡萄牙一项观察性队列起始研究的结果
Patient Prefer Adherence. 2018 Aug 17;12:1471-1482. doi: 10.2147/PPA.S170134. eCollection 2018.
7
Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice.艾塞那肽在口服降糖药治疗控制不佳的韩国2型糖尿病患者中的有效性和安全性：一项真实临床实践中的观察性研究
BMC Endocr Disord. 2017 Oct 25;17(1):68. doi: 10.1186/s12902-017-0220-4.
8
Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study).维格列汀在临床实践中的疗效：三项韩国观察性研究的汇总分析（VICTORY 研究）。
J Diabetes Res. 2017;2017:5282343. doi: 10.1155/2017/5282343. Epub 2017 Aug 24.
9
Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus.对10501名糖尿病患者常规使用持续葡萄糖监测。
Diabet Med. 2015 Dec;32(12):1568-74. doi: 10.1111/dme.12825. Epub 2015 Jul 14.
A historical perspective on clinical trials innovation and leadership: where have the academics gone?
临床试验创新与领导力的历史视角：学者们都去哪儿了？
JAMA. 2011 Feb 16;305(7):713-4. doi: 10.1001/jama.2011.175.